[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: Lung cancer mortality from radon versus mortality from
Barbara,
My comment to Howard is that he seems to be confused about LNT and
brachytherapy. Of course, if you can relate the doses delivered to the
radiaton therapy delivered by a competent physician and staff to his
ramblings about LD50 and pharmaceuticals, you understand more than I do
about his ramblings.
--John
John Jacobus, MS
Certified Health Physicist
3050 Traymore Lane
Bowie, MD 20715-2024
jenday1@email.msn.com (H)
The original comment was:
**Furthermore, LNT for chemicals is incompatible with the daily practice
of any physician, as we carefully dose poisons (most pharmaceuticals having
LD 50s, like ionizing radiation). Prescribing radiation UNDER THRESHHOLD
DOSE should soon be boosting immunity to infections (as in AIDS), speeding
wound
healing, and stimulating resistance to cancer. Now, it minimizes restenosis
in coronary stents. Would you prohibit - or delay - individual choice of
these dose-dependent benefits? **
Barabara L. Hamrick wrote:
to Howard:
> However, your
> comment about radiation to prevent restenosis makes me wonder how much you
>
Okay, now I'm curious, and have to butt in...It's my understanding, and
maybe
I'm totally misinformed, because I haven't been keeping up with medical
radiation research in the last year, but I THOUGHT that radiation WAS
effective in preventing restenosis...Isn't that what the Novoste Beta Cath
systems are all about?
. . .
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line. You can view the Radsafe archives at http://www.vanderbilt.edu/radsafe/